Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Recordati Rare Diseases, Immeuble Le Wilson, 70, avenue du Général de Gaulle, F-92800, Puteaux, France
Carbaglu 200 mg dispersible tablets.
| Pharmaceutical Form |
|---|
|
Dispersible tablet. The tablets are white and elongated with three score marks and engraved on one side. The tablet can be divided into equal halves. |
Each tablet contains 200 mg of carglumic acid.
For a full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Carglumic acid is a carbamoyl phosphate synthetase 1 (CPS 1) allosteric modulator. CPS1 is found in the mitochondria and is the first enzyme of the urea cycle, which converts ammonia into urea. Carglumic acid acts as a replacement for N-acetylglutamate (NAG) in N-acetylglutamate synthase (NAGS) deficiency patients by activating CPS1 but it does not help to regulate the urea cycle. Carglumic acid indicated as adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme NAGS. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
5-, 15- or 60- high density polyethylene tablet containers closed by a child resistant polypropylene cap with a desiccant unit.
Not all pack sizes may be marketed.
Recordati Rare Diseases, Immeuble “Le Wilson”, 70, avenue du Général de Gaulle, F-92800, Puteaux, France
EU/1/02/246/001 (15 dispersible tablets)
EU/1/02/246/002 (60 dispersible tablets)
EU/1/02/246/003 (5 dispersible tablets)
Date of first authorisation: 24 January 2003
Date of renewal: 20 May 2008
| Drug | Countries | |
|---|---|---|
| CARBAGLU | Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.